FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
The risk appears small and data is mixed, but FDA wants patients to be aware. This story matters for AI & Agent Economy readers tracking app. Reported by arstechnica.com. Read the full original at the source link below.
Originally reported by arstechnica.com. AppNewsletter.com curates and briefs the ai & agent economy stories that matter. Our editorial policy →
Get the daily app signal